Registration Dossier

Administrative data

Description of key information

The structural analogue substance had a LD50 (oral, gavage) of ca. 6500 mg/kg bw in rats.

Key value for chemical safety assessment

Acute toxicity: via oral route

Endpoint conclusion
Endpoint conclusion:
no adverse effect observed
Dose descriptor:
LD50
6 500 mg/kg bw

Additional information

Justification for classification or non-classification

Based on the oral LD50 of 6500 mg/kg bw for the structural analogue substance which is far above the cut-off criterion (2000 mg/kg bw), the substance is not classifiable according to the CLP Regulation.